IRS2 and osteoporosis: In another study, miR‐7b‐5p was found to inhibit the adipogenic differentiation of human BMSCs via insulin receptor substrate 2 (IRS2) targeting, thus alleviating the development of osteoporosis (Li et al., 2019b).